Physician
Interventional Pain Management
Interventional Pain Management was paid $215K by Medicaid between Jan 2018 and Oct 2024, across 19 billing codes. Its largest line is 64483, — 28% of everything it billed.
33Billing provider infoINTERVENTIONAL PAIN MANAGEMENT
FLORISSANT, MO 63031
FLORISSANT, MO 63031
33aNPI1710018247assigned 03/08/2007
33bProvider typeInterventional Pain Medicine Physician
28Total paid$215K
24GClaims14,888
24DCodes billed19
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Missouri
Rank by total paid#4 of 12
Median peer was paid$39K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,387 | $33K | |
| 2019 | 1,602 | $20K | |
| 2020 | 1,458 | $17K | |
| 2021 | 2,167 | $37K | |
| 2022 | 1,689 | $27K | |
| 2023 | 3,219 | $43K | |
| 2024incomplete | 2,366 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 64483 | 28% | 1,263 | 1,067 | $60K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 3,147 | 2,597 | $58K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 3,555 | 2,857 | $37K |
| 64484 | 6.1% | 659 | 559 | $13K | |
| 93923 | 4.7% | 923 | 365 | $10K | |
| 95924 | 3.5% | 453 | 360 | $7K | |
| 95923 | 2.8% | 462 | 361 | $6K | |
| 72275 | 2.2% | 319 | 290 | $5K | |
| 64493 | 2.1% | 165 | 134 | $5K | |
| 64479 | 1.8% | 66 | 50 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 1,045 | 886 | $3K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 132 | 78 | $2K |
7 more codes
| 64494 | <1% | 132 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,557 | $2K |
| 93040 | <1% | 445 | $789.13 | |
| 64490 | <1% | 12 | $446.84 | |
| 64480 | <1% | 13 | $427.22 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 455 | $228.14 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 85 | $162.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUNAPOOTI, MAHENDRA (PRESIDENT)